메뉴 건너뛰기




Volumn 50, Issue 5, 2010, Pages 544-553

Comparative pharmacokinetics of a once-daily tramadol extended-release tablet and an immediate-release reference product following single-dose and multiple-dose administration

Author keywords

Extended release; Once daily; Pharmacokinetics; Tramadol

Indexed keywords

O NORTRAMADOL; RYZOLT; TRAMADOL; UNCLASSIFIED DRUG;

EID: 77951172713     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009347673     Document Type: Article
Times cited : (12)

References (34)
  • 1
    • 0032062984 scopus 로고    scopus 로고
    • Tramadol hydrochloride: An overview of current use
    • Bamigbade TA, Langford RM Tramadol hydrochloride: an overview of current use. Hosp Med. 1998 ; 59: 373-376.
    • (1998) Hosp Med , vol.59 , pp. 373-376
    • Bamigbade, T.A.1    Langford, R.M.2
  • 2
    • 0026512239 scopus 로고
    • Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic
    • Raffa RB, Friderichs E., Reimann W., et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther. 1992 ; 260: 275-285.
    • (1992) J Pharmacol Exp Ther , vol.260 , pp. 275-285
    • Raffa, R.B.1    Friderichs, E.2    Reimann, W.3
  • 3
    • 0027429714 scopus 로고
    • Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol
    • Raffa RB, Friderichs E., Reimann W., et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther. 1993 ; 267: 331-340.
    • (1993) J Pharmacol Exp Ther , vol.267 , pp. 331-340
    • Raffa, R.B.1    Friderichs, E.2    Reimann, W.3
  • 4
    • 0030463064 scopus 로고    scopus 로고
    • The basic science aspect of tramadol hydrochloride
    • Raffa RB, Friderichs E. The basic science aspect of tramadol hydrochloride. Pain Rev. 1996 ; 3: 249-271.
    • (1996) Pain Rev , vol.3 , pp. 249-271
    • Raffa, R.B.1    Friderichs, E.2
  • 5
    • 0030033533 scopus 로고    scopus 로고
    • Contribution of monoaminergic modulation to the analgesic effect of tramadol
    • Desmeules JA, Piguet V., Collart L., et al. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol. 1996 ; 41: 7-12.
    • (1996) Br J Clin Pharmacol , vol.41 , pp. 7-12
    • Desmeules, J.A.1    Piguet, V.2    Collart, L.3
  • 6
    • 0030842909 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: Contrasting therapies for the treatment of chronic pain
    • Aronson MD Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther. 1997 ; 19: 420-432.
    • (1997) Clin Ther , vol.19 , pp. 420-432
    • Aronson, M.D.1
  • 7
    • 33746989258 scopus 로고    scopus 로고
    • Overview of oral modified-release opioid products for the management of chronic pain
    • Amabile CM, Bowman BJ Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacother. 2006 ; 40: 1327-1335.
    • (2006) Ann Pharmacother , vol.40 , pp. 1327-1335
    • Amabile, C.M.1    Bowman, B.J.2
  • 8
    • 0041909442 scopus 로고    scopus 로고
    • Recommendations for using opioids in chronic non-cancer pain
    • Kalso E., Allan L., Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003 ; 7: 381-386.
    • (2003) Eur J Pain , vol.7 , pp. 381-386
    • Kalso, E.1    Allan, L.2    Dellemijn, P.L.3
  • 9
    • 0142212136 scopus 로고    scopus 로고
    • The use of long-acting opioids in chronic pain management
    • Vallerand AH The use of long-acting opioids in chronic pain management. Nurs Clin North Am. 2003 ; 38: 435-445.
    • (2003) Nurs Clin North Am , vol.38 , pp. 435-445
    • Vallerand, A.H.1
  • 10
    • 45949106973 scopus 로고    scopus 로고
    • Chronic pain of osteoarthritis: Considerations for selecting an extended-release opioid analgesic
    • Gibofsky A., Barkin RL Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic. Am J Ther. 2008 ; 15: 241-255.
    • (2008) Am J Ther , vol.15 , pp. 241-255
    • Gibofsky, A.1    Barkin, R.L.2
  • 11
    • 0034871011 scopus 로고    scopus 로고
    • A systematic review of the associations between dose regimens and medication compliance
    • Claxton AJ, Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001 ; 23: 1296-1310.
    • (2001) Clin Ther , vol.23 , pp. 1296-1310
    • Claxton, A.J.1    Cramer, J.2    Pierce, C.3
  • 12
    • 58249127833 scopus 로고    scopus 로고
    • Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain
    • Nicholson B. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain. Pain Pract. 2008 ; 9: 71-81.
    • (2008) Pain Pract , vol.9 , pp. 71-81
    • Nicholson, B.1
  • 13
    • 39849098437 scopus 로고    scopus 로고
    • Advanced formulation design: Improving drug therapies for the management of severe and chronic pain
    • Miller DA, Dinunzio JC, Williams RO III. Advanced formulation design: improving drug therapies for the management of severe and chronic pain. Drug Dev Ind Pharm. 2008 ; 34: 117-133.
    • (2008) Drug Dev Ind Pharm , vol.34 , pp. 117-133
    • Miller, D.A.1    Dinunzio, J.C.2    Williams III, R.O.3
  • 14
    • 4644357395 scopus 로고    scopus 로고
    • Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: A randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee
    • Mongin G., Yakusevich V., Köpe A., et al. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin Drug Investig. 2004 ; 24: 545-558.
    • (2004) Clin Drug Investig , vol.24 , pp. 545-558
    • Mongin, G.1    Yakusevich, V.2    Köpe, A.3
  • 15
    • 0022497847 scopus 로고
    • Bioavailability of enteral tramadol formulations. 1st communication: Capsules
    • Lintz W., Barth H., Osterloh G., et al. Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung. 1986 ; 36: 1278-1283.
    • (1986) Arzneimittelforschung , vol.36 , pp. 1278-1283
    • Lintz, W.1    Barth, H.2    Osterloh, G.3
  • 17
    • 34548728684 scopus 로고    scopus 로고
    • Pharmacokinetics and dose proportionality of three Tramadol Contramid OAD tablet strengths
    • Karhu D., El- Jammal A., Dupain T., et al. Pharmacokinetics and dose proportionality of three Tramadol Contramid OAD tablet strengths. Biopharm Drug Dispos. 2007 ; 28: 323-330.
    • (2007) Biopharm Drug Dispos , vol.28 , pp. 323-330
    • Karhu, D.1    Jammal, A.2    Dupain, T.3
  • 18
  • 19
    • 0020662337 scopus 로고
    • Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals
    • Steinijans VW, Diletti E. Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur J Clin Pharmacol. 1983 ; 24: 127-136.
    • (1983) Eur J Clin Pharmacol , vol.24 , pp. 127-136
    • Steinijans, V.W.1    Diletti, E.2
  • 20
    • 37149028732 scopus 로고    scopus 로고
    • Tramadol extended-release formulations in the management of pain due to osteoarthritis
    • Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother. 2007 ; 7: 1775-1784.
    • (2007) Expert Rev Neurother , vol.7 , pp. 1775-1784
    • Mongin, G.1
  • 21
    • 34548503599 scopus 로고    scopus 로고
    • A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis
    • Burch F., Fishman R., Messina N., et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage. 2007 ; 34: 328-338.
    • (2007) J Pain Symptom Manage , vol.34 , pp. 328-338
    • Burch, F.1    Fishman, R.2    Messina, N.3
  • 22
    • 37249065725 scopus 로고    scopus 로고
    • Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD)
    • Fishman RL, Kistler CJ, Ellerbusch MT, et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag. 2007 ; 3: 273-280.
    • (2007) J Opioid Manag , vol.3 , pp. 273-280
    • Fishman, R.L.1    Kistler, C.J.2    Ellerbusch, M.T.3
  • 23
    • 0032789677 scopus 로고    scopus 로고
    • Pharmacokinetic properties of tramadol sustained release capsules: 3rd Communication: Investigation of relative bioavailability under steady state conditions
    • Raber M., Schulz HU, Schurer M., et al. Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions. Arzneimittelforschung. 1999 ; 49: 594-598. (Pubitemid 29334753)
    • (1999) Arzneimittel-Forschung/Drug Research , vol.49 , Issue.7 , pp. 594-598
    • Raber, M.1    Schulz, H.-U.2    Schurer, M.3    Krupp, S.4    Momberger, H.5
  • 24
    • 33751118259 scopus 로고    scopus 로고
    • Tramadol extended-release tablets
    • Hair PI, Curran MP, Keam SJ Tramadol extended-release tablets. Drugs. 2006 ; 66: 2017-2027.
    • (2006) Drugs , vol.66 , pp. 2017-2027
    • Hair, P.I.1    Curran, M.P.2    Keam, S.J.3
  • 25
    • 0033062444 scopus 로고    scopus 로고
    • Analgesic efficacy and tolerability of tramadol 100mg sustained-release capsules in patients with moderate to severe chronic low back pain
    • Raber M., Hofmann S., Junge K., et al. Analgesic efficacy and tolerability of tramadol 100mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Investig. 1999 ; 17: 415-423.
    • (1999) Clin Drug Investig , vol.17 , pp. 415-423
    • Raber, M.1    Hofmann, S.2    Junge, K.3
  • 27
    • 0029979756 scopus 로고    scopus 로고
    • Pharmacology and clinical experience with tramadol in osteoarthritis
    • Katz WA Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs. 1996 ; 52: 39-47.
    • (1996) Drugs , vol.52 , pp. 39-47
    • Katz, W.A.1
  • 28
    • 57149112767 scopus 로고    scopus 로고
    • Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain
    • Sarbu A., Radulescu F., Robertson S., et al. Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain. J Opioid Manag. 2008 ; 4: 285-292.
    • (2008) J Opioid Manag , vol.4 , pp. 285-292
    • Sarbu, A.1    Radulescu, F.2    Robertson, S.3
  • 30
    • 77951153290 scopus 로고    scopus 로고
    • Biovail Corporation. http://www.biovail.com/. Accessed January 14, 2009.
    • (2009) Biovail Corporation
  • 32
    • 34547196422 scopus 로고    scopus 로고
    • Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites
    • Eradiri O., Sista S., Lai JC, et al. Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites. Curr Med Res Opin. 2007 ; 23: 1593-1604.
    • (2007) Curr Med Res Opin , vol.23 , pp. 1593-1604
    • Eradiri, O.1    Sista, S.2    Lai, J.C.3
  • 33
    • 41349099452 scopus 로고    scopus 로고
    • Extended-release tramadol (ULTRAM ER): A pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain
    • Barkin RL Extended-release tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008 ; 15: 157-166.
    • (2008) Am J Ther , vol.15 , pp. 157-166
    • Barkin, R.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.